Abstract
Several fetal therapies have become standard in prenatal care; however, there are no available fetal treatment options for genetic disorders. In utero stem cell transplantation (IUTx) and in utero gene therapy (IUGT) may become recognized as viable strategies for treating selective congenital genetic disorders in the near future. The advantages and disadvantages of fetal stem cell transplantation and gene therapy are discussed. The limit of the therapeutic effects after birth must be clarified, along with the safety of treatment during the fetal period for each treatment before clinical application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
